Daniel A Rossignol

Summary

Publications

  1. pmc Hyperbaric oxygen treatment in autism spectrum disorders
    Daniel A Rossignol
    Rossignol Medical Center, 3800 West Eau Gallie Blvd, Melbourne, FL, 32934, USA
    Med Gas Res 2:16. 2012
  2. pmc A review of research trends in physiological abnormalities in autism spectrum disorders: immune dysregulation, inflammation, oxidative stress, mitochondrial dysfunction and environmental toxicant exposures
    D A Rossignol
    International Child Development Resource Center, Melbourne, FL 32934, USA
    Mol Psychiatry 17:389-401. 2012
  3. pmc Hyperbaric oxygen treatment for inflammatory bowel disease: a systematic review and analysis
    Daniel A Rossignol
    Rossignol Medical Center, 3800 West Eau Gallie Blvd, Melbourne, FL 32934, USA
    Med Gas Res 2:6. 2012
  4. pmc Mitochondrial dysfunction in autism spectrum disorders: a systematic review and meta-analysis
    D A Rossignol
    International Child Development Resource Center, Melbourne, FL 32934, USA
    Mol Psychiatry 17:290-314. 2012
  5. pmc The effects of hyperbaric oxygen therapy on oxidative stress, inflammation, and symptoms in children with autism: an open-label pilot study
    Daniel A Rossignol
    International Child Development Resource Center, 3800 West Eau Gallie Blvd, Suite 105, Melbourne, FL 32934, USA
    BMC Pediatr 7:36. 2007
  6. pmc Hyperbaric treatment for children with autism: a multicenter, randomized, double-blind, controlled trial
    Daniel A Rossignol
    International Child Development Resource Center, Melbourne, FL, USA
    BMC Pediatr 9:21. 2009
  7. ncbi request reprint Novel and emerging treatments for autism spectrum disorders: a systematic review
    Daniel A Rossignol
    International Child Development Resource Center, Melbourne, FL 32934, USA
    Ann Clin Psychiatry 21:213-36. 2009
  8. doi request reprint Melatonin in autism spectrum disorders: a systematic review and meta-analysis
    Daniel A Rossignol
    International Child Development Resource Center, Melbourne, FL, USA
    Dev Med Child Neurol 53:783-92. 2011
  9. ncbi request reprint Biomarker-guided interventions of clinically relevant conditions associated with autism spectrum disorders and attention deficit hyperactivity disorder
    James Jeffrey Bradstreet
    International Child Development Resource Center, Melbourne, FL 32934, USA
    Altern Med Rev 15:15-32. 2010

Detail Information

Publications9

  1. pmc Hyperbaric oxygen treatment in autism spectrum disorders
    Daniel A Rossignol
    Rossignol Medical Center, 3800 West Eau Gallie Blvd, Melbourne, FL, 32934, USA
    Med Gas Res 2:16. 2012
    ....
  2. pmc A review of research trends in physiological abnormalities in autism spectrum disorders: immune dysregulation, inflammation, oxidative stress, mitochondrial dysfunction and environmental toxicant exposures
    D A Rossignol
    International Child Development Resource Center, Melbourne, FL 32934, USA
    Mol Psychiatry 17:389-401. 2012
    ..Further research into these physiological areas may provide insight into general or subset-specific processes that could contribute to the development of ASD and other psychiatric disorders...
  3. pmc Hyperbaric oxygen treatment for inflammatory bowel disease: a systematic review and analysis
    Daniel A Rossignol
    Rossignol Medical Center, 3800 West Eau Gallie Blvd, Melbourne, FL 32934, USA
    Med Gas Res 2:6. 2012
    ..abstract:..
  4. pmc Mitochondrial dysfunction in autism spectrum disorders: a systematic review and meta-analysis
    D A Rossignol
    International Child Development Resource Center, Melbourne, FL 32934, USA
    Mol Psychiatry 17:290-314. 2012
    ..Overall, this evidence supports the notion that mitochondrial dysfunction is associated with ASD. Additional studies are needed to further define the role of mitochondrial dysfunction in ASD...
  5. pmc The effects of hyperbaric oxygen therapy on oxidative stress, inflammation, and symptoms in children with autism: an open-label pilot study
    Daniel A Rossignol
    International Child Development Resource Center, 3800 West Eau Gallie Blvd, Suite 105, Melbourne, FL 32934, USA
    BMC Pediatr 7:36. 2007
    ..Changes in markers of oxidative stress and inflammation were measured. The children were evaluated to determine clinical effects and safety...
  6. pmc Hyperbaric treatment for children with autism: a multicenter, randomized, double-blind, controlled trial
    Daniel A Rossignol
    International Child Development Resource Center, Melbourne, FL, USA
    BMC Pediatr 9:21. 2009
    ..We performed a multicenter, randomized, double-blind, controlled trial to assess the efficacy of hyperbaric treatment in children with autism...
  7. ncbi request reprint Novel and emerging treatments for autism spectrum disorders: a systematic review
    Daniel A Rossignol
    International Child Development Resource Center, Melbourne, FL 32934, USA
    Ann Clin Psychiatry 21:213-36. 2009
    ..Perhaps for this reason, the use of novel, unconventional, and off-label treatments for ASD is common, with up to 74% of children with ASD using these treatments; however, treating physicians are often unaware of this usage...
  8. doi request reprint Melatonin in autism spectrum disorders: a systematic review and meta-analysis
    Daniel A Rossignol
    International Child Development Resource Center, Melbourne, FL, USA
    Dev Med Child Neurol 53:783-92. 2011
    ..The aim of this study was to investigate melatonin-related findings in autism spectrum disorders (ASD), including autistic disorder, Asperger syndrome, Rett syndrome, and pervasive developmental disorders, not otherwise specified...
  9. ncbi request reprint Biomarker-guided interventions of clinically relevant conditions associated with autism spectrum disorders and attention deficit hyperactivity disorder
    James Jeffrey Bradstreet
    International Child Development Resource Center, Melbourne, FL 32934, USA
    Altern Med Rev 15:15-32. 2010
    ..The use of these biomarkers is of great importance in young children with ADHD or individuals of any age with ASD, because typically they cannot adequately communicate regarding their symptoms...